New Genetic Testing Program for hATTR patients
Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for Patients with Suspected Hereditary ATTR Amyloidosis. To learn more, please visit the website.
Let's get in touch
Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.